Featured

24 January 2024

ACCORD: new guideline to support consistent and complete reporting of consensus methods in biomedical research

Oxford PharmaGenesis has contributed to the development of the new ACCORD reporting guideline to help the medical and scientific communities to improve the reporting of research involving consensus methodologies. The guideline was published in the non-profit open access journal PLOS Medicine.

All
  • All
  • News
  • Articles
  • Events

Highlights from the 2021 Asia Pacific Meeting of ISMPP

Members of the Oxford PharmaGenesis team in Melbourne recently attended the 2021 Asia Pacific (APAC) meeting of the International Society for Medical Publication Professionals (ISMPP), a virtual event held on 9 and 10 September 2021. Oxford PharmaGenesis was a proud Ruby Sponsor of this stimulating meeting, which showcased the latest advances in scientific communications and…

Continue reading

Oxford PharmaGenesis wins big at the PMLiVE Communiqué Awards 2021

Oxford PharmaGenesis won big at the PMLiVE Communiqué Awards 2021 on Wednesday 1 September, winning in two categories entered: Medical affairs agency of the year and Excellence in global education meetings/stand-alone events.

Continue reading

Oxford PharmaGenesis backs clinical trials education campaign

Oxford PharmaGenesis is proud to sponsor a dedicated supplement in USA Today, helping raise awareness of clinical trials. The June 2021 supplement aims to increase the visibility and public understanding of clinical trials, and help patients to prepare and navigate the clinical trials process. Oxford PharmaGenesis stands alongside several global pharmaceutical companies in supporting this…

Continue reading

Oxford PharmaGenesis launches dedicated Informatics and Data Science Practice

A new, dedicated Informatics and Data Science Practice is poised to optimize data insights for Oxford PharmaGenesis clients. The practice builds on more than 20 years of in-house experience, and will take advantage of the growing and evolving volume of biomedical data sources within healthcare.

Continue reading

Oxford PharmaGenesis CEO walks 65 km for Jacari

Over the weekend of 12–13 June 2021, Oxford PharmaGenesis Chief Executive Officer Chris Winchester walked 65 km from Stratford-upon-Avon to central Birmingham, raising £450 for children’s tutoring charity Jacari. To celebrate its sixty-fifth anniversary, the award-winning children’s charity Jacari has challenged its supporters to run, walk, cycle or swim 65 km in 65 days to help raise…

Continue reading

Oxford PharmaGenesis partners with Sobell House to support life-enhancing care

Oxford PharmaGenesis has joined the Sobell Business Club, opening up new opportunities to engage with Oxfordshire’s exceptional Sobell House Hospice and the local community. This follows Oxford PharmaGenesis’s fundraising in partnership with the Rotary Club of Oxford North during our Chairman Graham Shelton’s time as Rotary Club President in 2020–21. Sobell House provides specialist palliative…

Continue reading